Literature DB >> 15930101

Gsh2 is required for the repression of Ngn1 and specification of dorsal interneuron fate in the spinal cord.

Sonja Kriks1, Guillermo M Lanuza, Rumiko Mizuguchi, Masato Nakafuku, Martyn Goulding.   

Abstract

The molecular programs that specify progenitors in the dorsal spinal cord remain poorly defined. The homeodomain transcription factor Gsh2 is expressed in the progenitors of three dorsal interneuron subtypes, dI3, dI4 and dI5 neurons, whereas Gsh1 is only expressed in dI4 and dI5 progenitors. Mice lacking Gsh2 exhibit a selective loss of dI3 interneurons that is accompanied by an expansion of the dI2 progenitor domain. In Gsh2 mutant embryos, expression of the proneural bHLH protein Mash1 is downregulated in dI3 neural progenitors, with Mash1 mutants exhibiting a concordant reduction in dI3 neurons. Conversely, overexpression of Gsh2 and Mash1 leads to the ectopic production of dI3 neurons and a concomitant repression of Ngn1 expression. Our results provide evidence that genetic interactions involving repression of Ngn1 by Gsh2 promote the differentiation of dI3 neurons from class A progenitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930101     DOI: 10.1242/dev.01878

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  18 in total

1.  Canonical BMP7 activity is required for the generation of discrete neuronal populations in the dorsal spinal cord.

Authors:  Gwenvael Le Dréau; Lidia Garcia-Campmany; M Angeles Rabadán; Tiago Ferronha; Samuel Tozer; James Briscoe; Elisa Martí
Journal:  Development       Date:  2011-12-07       Impact factor: 6.868

2.  Neurogenin 1 (Neurog1) expression in the ventral neural tube is mediated by a distinct enhancer and preferentially marks ventral interneuron lineages.

Authors:  Herson I Quiñones; Trisha K Savage; James Battiste; Jane E Johnson
Journal:  Dev Biol       Date:  2010-02-18       Impact factor: 3.582

3.  Sequential roles for Mash1 and Ngn2 in the generation of dorsal spinal cord interneurons.

Authors:  Amy W Helms; James Battiste; R Michael Henke; Yuji Nakada; Nicolas Simplicio; Francois Guillemot; Jane E Johnson
Journal:  Development       Date:  2005-05-18       Impact factor: 6.868

4.  Linking pattern formation to cell-type specification: Dichaete and Ind directly repress achaete gene expression in the Drosophila CNS.

Authors:  Guoyan Zhao; Grace Boekhoff-Falk; Beth A Wilson; James B Skeath
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

Review 5.  How do genes regulate simple behaviours? Understanding how different neurons in the vertebrate spinal cord are genetically specified.

Authors:  Katharine E Lewis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

6.  Gsx2 controls region-specific activation of neural stem cells and injury-induced neurogenesis in the adult subventricular zone.

Authors:  Alejandro López-Juárez; Jennifer Howard; Kristy Ullom; Lindsey Howard; Andrew Grande; Andrea Pardo; Ronald Waclaw; Yu-Yo Sun; Dianer Yang; Chia-Yi Kuan; Kenneth Campbell; Masato Nakafuku
Journal:  Genes Dev       Date:  2013-05-30       Impact factor: 11.361

Review 7.  Making sense out of spinal cord somatosensory development.

Authors:  Helen C Lai; Rebecca P Seal; Jane E Johnson
Journal:  Development       Date:  2016-10-01       Impact factor: 6.868

8.  Homeobox genes Gsx1 and Gsx2 differentially regulate telencephalic progenitor maturation.

Authors:  Zhenglei Pei; Bei Wang; Gang Chen; Motoshi Nagao; Masato Nakafuku; Kenneth Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

Review 9.  Building a bridal chamber: development of the thalamus.

Authors:  Steffen Scholpp; Andrew Lumsden
Journal:  Trends Neurosci       Date:  2010-06-11       Impact factor: 13.837

Review 10.  Mechanisms regulating GABAergic neuron development.

Authors:  Kaia Achim; Marjo Salminen; Juha Partanen
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.